Itraconazole

Edina Avdic, Pharm.D.
Pediatric Dosing Author: Lisa Hutchins, Pharm.D.

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • Following fungal infections in immunocompromised and non-immunocompromised patients:
    • Aspergillosis: treatment-intolerant of or refractory to amphotericin B therapy
    • Pulmonary and extrapulmonary blastomycosis
    • Histoplasmosis, including chronic cavitary pulmonary disease and disseminated non-meningeal histoplasmosis
  • Onychomycosis in non-immunocompromised patients (oral capsule):
    • Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)
    • Onychomycosis of the fingernail due to dermatophytes (tinea unguium).
  • Oropharyngeal and esophageal candidiasis (oral liquid)
  • Neutropenic fever in patients with suspected fungal infection (oral liquid).

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • Coccidioidomycosis
  • Cryptococcosis (fluconazole preferred)
  • Penicilliosis
  • Sporotrichosis
  • Candida vaginitis
  • Fluconazole-resistant esophageal candidiasis

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved